Ge Healthcare Technologies Inc (GEHC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,552,000 | 1,088,000 | 588,000 | 2,050,000 | 1,312,000 |
| Depreciation Amortization | 432,000 | 284,000 | 136,000 | 580,000 | 440,000 |
| Accounts receivable | -6,000 | 185,000 | 81,000 | -153,000 | 101,000 |
| Accounts payable and accrued liabilities | -119,000 | -113,000 | 146,000 | 65,000 | -67,000 |
| Other Working Capital | -617,000 | -612,000 | -244,000 | -133,000 | -335,000 |
| Other Operating Activity | -305,000 | -488,000 | -457,000 | -454,000 | -409,000 |
| Operating Cash Flow | $937,000 | $344,000 | $250,000 | $1,955,000 | $1,042,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -348,000 | -238,000 | -152,000 | -401,000 | -299,000 |
| Net Acquisitions | -279,000 | -279,000 | -269,000 | -313,000 | -259,000 |
| Purchase Of Investment | -82,000 | -28,000 | -20,000 | -40,000 | -33,000 |
| Other Investing Activity | -69,000 | -85,000 | 34,000 | -160,000 | -83,000 |
| Investing Cash Flow | $-778,000 | $-630,000 | $-407,000 | $-914,000 | $-674,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,000 | 1,000 | N/A | N/A |
| Debt Issued | 1,494,000 | 1,493,000 | N/A | 995,000 | 994,000 |
| Debt Repayment | -265,000 | -261,000 | -257,000 | -1,418,000 | -162,000 |
| Common Stock Issued | 25,000 | 21,000 | 20,000 | 33,000 | 31,000 |
| Common Stock Repurchased | -200,000 | -100,000 | N/A | N/A | N/A |
| Dividend Paid | -48,000 | -32,000 | -16,000 | -55,000 | -41,000 |
| Other Financing Activity | -96,000 | -47,000 | -34,000 | -128,000 | -118,000 |
| Financing Cash Flow | $910,000 | $1,075,000 | $-286,000 | $-573,000 | $704,000 |
| Exchange Rate Effect | 68,000 | 84,000 | 27,000 | -77,000 | -2,000 |
| Beginning Cash Position | 2,893,000 | 2,893,000 | 2,893,000 | 2,506,000 | 2,506,000 |
| End Cash Position | 4,030,000 | 3,766,000 | 2,476,000 | 2,893,000 | 3,572,000 |
| Net Cash Flow | $1,137,000 | $873,000 | $-416,000 | $387,000 | $1,066,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 937,000 | 344,000 | 250,000 | 1,955,000 | 1,042,000 |
| Capital Expenditure | -348,000 | -238,000 | -152,000 | -401,000 | -299,000 |
| Free Cash Flow | 589,000 | 106,000 | 98,000 | 1,554,000 | 743,000 |